Johnson & Johnson vaccine production is behind schedule: report

/ / News

Federal officials have been told that Johnson & Johnson’s vaccine production has fallen as much as two months behind the original production schedule and won’t catch up until the end of April, The New York Times reported, citing people familiar with the situations. The report quoted the lead manufacturing adviser for Operation Warp Speed that the company might be able to catch up with initial production goals by March. Johnson & Johnson may release results from its COVID-19 vaccine, which is unique in that it only requires a single dose, in as little as two weeks, the report adds.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.